Plain-English translation of NCT07112820 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a special type of heart ultrasound with contrast dye (called Sonovue) can help doctors diagnose heart attacks more accurately when patients arrive at the hospital with symptoms. Right now, doctors often have to do an invasive procedure (threading a tube into the heart arteries) to confirm whether someone has had a heart attack. The researchers want to see if this safer ultrasound imaging can help avoid unnecessary invasive procedures by distinguishing a real heart attack from other conditions that look similar.
Many patients who come to the hospital with chest pain have unclear symptoms, and doctors can't always tell right away if they've had a heart attack. This sometimes leads to unnecessary invasive heart procedures that carry their own risks. This study aims to find a safer, non-invasive way to quickly and accurately diagnose heart attacks using improved ultrasound imaging.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will receive a special ultrasound of your heart using a contrast dye (Sonovue) while you're in the hospital for your suspected heart attack. This ultrasound helps doctors see blood flow in your heart muscle more clearly. You will also undergo the standard heart procedure (coronary angiography) that your doctors have already planned within 72 hours. The study team will track how well the ultrasound imaging helped doctors diagnose your condition compared to the standard procedure.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
France